The Technical Analyst
Select Language :
Biophytis SA American [BPTS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Biophytis SA American Price, Forecast, Insider, Ratings, Fundamentals & Signals

Biophytis SA American is listed at the  Exchange

-3.57% €0.351

America/New_York / 28 mar 2024 @ 16:00


Biophytis SA American: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 4.11 mill
EPS: -8.67
P/E: -0.0400
Earnings Date: Mar 27, 2024
SharesOutstanding: 11.70 mill
Avg Daily Volume: 0.0672 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/212/224/224/222/232/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebitn/an/an/an/an/an/a
Asset n/an/an/an/a
Debtn/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0400 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.01x
Company: PE -0.0400 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

€ 0.286 - 0.416

( +/- 18.52%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €0.351
Forecast 2: 16:00 - €0.351
Forecast 3: 16:00 - €0.351
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €0.351 (-3.57% )
Volume 0.0427 mill
Avg. Vol. 0.0672 mill
% of Avg. Vol 63.55 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Biophytis SA American Depositary Share

Last 12 Months

Last 12 months chart data with high, low, open and close for Biophytis SA American Depositary Share

RSI

Intraday RSI14 chart for Biophytis SA American Depositary Share

Last 10 Buy & Sell Signals For BPTS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Biophytis SA American Depositary Share

BPTS

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Last 10 Buy Signals

Date Signal @
FETUSDMar 29 - 04:58$3.24
SOCKSUSDMar 29 - 04:5335 606
OSHIUSDMar 29 - 04:4981.91
HBTCUSDMar 29 - 04:3834 558
DESOUSDMar 29 - 04:3931.41
ARUSDMar 29 - 04:28$41.19
KCSUSDMar 29 - 04:24$11.87
FTNUSDMar 29 - 04:141.819
ORAIUSDMar 29 - 04:0814.59
IONUSDMar 29 - 04:08452.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.